Gaston-Dreyfus Remi
Insider CIK 1716639 · BNKL Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BNKL Bionik Laboratories Corp. | C Conversion | 2023-06-13 | 2023-06-21 | 3,102,878 | $0.60 | $1.86M | 4,917,749 | SEC↗ |
| BNKL Bionik Laboratories Corp. | P Buy | 2023-06-09 | 2023-06-21 | 180,555 | $0.60 | $108.3K | 1,814,871 | SEC↗ |
| BNKL Bionik Laboratories Corp. | C Conversion | 2022-03-31 | 2022-06-21 | 77,887 | $9.50 | $739.9K | 1,616,840 | SEC↗ |
| BNKL Bionik Laboratories Corp. | M Exercise deriv | 2021-07-15 | 2021-12-13 | 115,759 | — | $0 | 0 | SEC↗ |
| BNKL Bionik Laboratories Corp. | M Exercise deriv | 2021-07-15 | 2021-12-13 | 5,000 | — | $0 | 0 | SEC↗ |
| BNKL Bionik Laboratories Corp. | M Exercise | 2021-07-15 | 2021-12-13 | 5,000 | — | $0 | 1,600,209 | SEC↗ |
| BNKL Bionik Laboratories Corp. | M Exercise | 2021-07-15 | 2021-12-13 | 115,759 | — | $0 | 1,595,209 | SEC↗ |
| BNKL Bionik Laboratories Corp. | A Award | 2021-03-29 | 2021-12-13 | 61,256 | — | $0 | 1,479,450 | SEC↗ |
| BNKL Bionik Laboratories Corp. | P Buy | 2021-03-26 | 2021-12-13 | 135,560 | — | $0 | 1,418,194 | SEC↗ |
| BNKL Bionik Laboratories Corp. | C Conversion deriv | 2019-11-25 | 2019-11-27 | 4,997 | — | $0 | 17,476 | SEC↗ |
| BNKL Bionik Laboratories Corp. | C Conversion | 2019-11-25 | 2019-11-27 | 4,997 | — | $0 | 1,282,634 | SEC↗ |
| BNKL Bionik Laboratories Corp. | C Conversion | 2019-09-30 | 2019-10-03 | 76,225 | $6.80 | $518.3K | 1,277,637 | SEC↗ |
| BNKL Bionik Laboratories Corp. | P Buy | 2019-08-26 | 2019-08-28 | 106,358 | $3.76 | $399.9K | 1,201,412 | SEC↗ |
| BNKL Bionik Laboratories Corp. | A Award deriv | 2019-07-26 | 2019-07-30 | 115,759 | — | $0 | 115,759 | SEC↗ |
| BNKL Bionik Laboratories Corp. | A Award deriv | 2019-05-31 | 2019-06-04 | 5,000 | — | $0 | 5,000 | SEC↗ |
| BNKL Bionik Laboratories Corp. | C Conversion | 2019-03-28 | 2019-04-05 | 197,234 | $3.89 | $767.2K | 1,095,054 | SEC↗ |
| BNKL Bionik Laboratories Corp. | C Conversion | 2018-07-24 | 2018-07-26 | 43,468,547 | $0.05 | $2.17M | 134,672,664 | SEC↗ |
| BNKL Bionik Laboratories Corp. | C Conversion | 2018-06-13 | 2018-06-28 | 15,740,728 | $0.06 | $944.4K | 91,204,117 | SEC↗ |
| BNKL Bionik Laboratories Corp. | C Conversion | 2018-03-31 | 2018-04-03 | 63,197,149 | $0.06 | $3.79M | 75,463,389 | SEC↗ |
| BNKL Bionik Laboratories Corp. | C Conversion | 2018-03-31 | 2018-04-03 | 12,266,240 | $0.06 | $736.0K | 75,463,389 | SEC↗ |
| BNKL Bionik Laboratories Corp. | A Award deriv | 2017-08-14 | 2018-04-03 | 5,858,343 | — | $0 | 5,858,343 | SEC↗ |
| BNKL Bionik Laboratories Corp. | A Award deriv | 2017-03-31 | 2018-04-03 | 1,600,640 | — | $0 | 3,361,344 | SEC↗ |
| BNKL Bionik Laboratories Corp. | A Award deriv | 2017-03-31 | 2018-04-03 | 1,760,704 | — | $0 | 3,361,344 | SEC↗ |